Regeneron Pharmaceuticals
Regeneron Pharmaceuticals/ US75886F1075 /
REGN
|
2025-03-14 8:59:59 PM
|
Chg.
-14.70
|
Volume |
Bid8:59:59 PM |
Ask2025-03-14 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
665.94USD
|
-2.16%
|
65,812
Turnover: 43.95 mill. |
665.94Bid Size: 183 |
666.97Ask Size: 200 |
72.91 bill.USD |
- |
16.30 |
Master data
| WKN: |
881535 |
| Ticker: |
REGN |
| Currency: |
USD |
| Type: |
Stock |
| Issue type: |
Common stock |
| Trading segment: |
- |
| Next exchange holiday: |
2025-04-18 |
|
Indices: Nasdaq 100, baha us 500, baha us tech 100
|
Quote data
| Open: |
678.01 |
| High: |
686.91 |
| Low: |
657.01 |
| Previous Close: |
680.64 |
| Volume (shares): |
65,812 |
| Turnover: |
43.95 mill. |
| Trades: |
2,104 |
| Market phase: |
OP |
All quotes in USD
Performance
| 1 Week |
|
|
-5.89% |
| 1 Month |
|
|
-1.13% |
| 3 Months |
|
|
-8.86% |
| YTD |
|
|
-6.55% |
| 1 Year |
|
|
-30.97% |
| 3 Years |
|
|
+0.04% |
| 5 Years |
|
|
+43.21% |
| 10 Years |
|
|
+55.09% |
| 1W High / 1W Low: |
745.17 |
665.94 |
| 1M High / 1M Low: |
745.17 |
665.94 |
| 6M High / 6M Low: |
1,153.07 |
662.56 |
| High (YTD): |
2025-03-10 |
745.17 |
| Low (YTD): |
2025-02-12 |
662.56 |
| 52W High: |
2024-08-27 |
1,202.24 |
| 52W Low: |
2025-02-12 |
662.56 |
| Avg. price 1W: |
|
699.64 |
| Avg. volume 1W: |
|
70,891.80 |
| Avg. price 1M: |
|
697.88 |
| Avg. volume 1M: |
|
47,990.16 |
| Avg. price 6M: |
|
805.00 |
| Avg. volume 6M: |
|
45,001.31 |
| Avg. price 1Y: |
|
918.90 |
| Avg. volume 1Y: |
|
32,530.43 |
| Volatility 1M: |
|
36.89% |
| Volatility 6M: |
|
30.31% |
| Volatility 1Y: |
|
25.12% |
| Volatility 3Y: |
|
27.22% |
| Dividend per Share: |
|
- |
| Earnings per Share: |
|
40.90 USD |
| Return on Equity: |
|
15.03% |
| Dividend Yield: |
|
- |
| P/E Ratio: |
|
16.30 |
| Market Capitalization: |
|
72.91 bill. USD |
| Free Float Market Cap.: |
|
- |
Sector comparison
|
|
| Amgen Inc. | Vertex Pharma... | Regeneron Pha... | Gilead Scienc... | Nasdaq 100 |
|
Overview
|
|
|
ISIN
|
| US0311621009 | US92532F1003 | US75886F1075 | US3755581036 | US6311011026 |
|
Market Capitalization
|
|
168.53 bill. USD | 129.62 bill. USD | 72.91 bill. USD | 138.78 bill. USD | - |
|
Shares Outstanding
|
|
537.2 mill. | 256.79 mill. | 107.51 mill. | 1.25 bill. | - |
|
Dividend per Share*
|
|
9.13 USD | - | - | 3.08 USD | - |
|
Dividend Yield
|
|
2.91% | - | - | 2.76% | - |
|
P/E Ratio
|
|
41.17 | - | 16.30 | 293.26 | - |
|
P/E Ratio (with EPS Diluted)*
|
|
34.48 | -193.61 | 18.58 | 243.08 | - |
|
Free Float
|
|
76.20% | 82.70% | 68.40% | 99.89% | - |
|
Performance
|
|
|
Exchange
|
| NASDAQ | NASDAQ | NASDAQ | NASDAQ | Indices Nasdaq |
|
1 Week
|
|
-3.43% | +3.38% | -5.74% | -5.08% | -2.46% |
|
1 Month
|
|
+7.74% | +9.97% | -1.00% | +7.07% | -10.90% |
|
3 Months
|
|
+15.92% | +8.85% | -8.81% | +21.32% | -9.53% |
|
YTD
|
|
+20.36% | +25.35% | -6.38% | +20.65% | -6.22% |
|
1 Year
|
|
+16.68% | +23.81% | -30.86% | +51.23% | +10.65% |
|
3 Years
|
|
+35.48% | +104.37% | +0.14% | +91.08% | +46.41% |
|
5 Years
|
|
+55.23% | +128.55% | +43.24% | +57.51% | +146.45% |
|
Fundamentals
|
| 2024 | 2024 | 2024 | 2024 | - |
|
Accounting Standard
|
| US GAAP | US GAAP | US GAAP | US GAAP | - |
|
Revenues
(in mill.)
|
|
33,424 USD | 11,020.1000 USD | 14,202 USD | 28,754 USD | - |
|
Revenues Growth Rate
|
|
18.57% | 11.66% | 8.27% | 6.04% | - |
|
EBITDA
(in mill.)
|
|
- | - | - | - | - |
|
Operating Result
(in mill.)
|
|
7,258 USD | -232.9000 USD | 3,990.7000 USD | 1,662 USD | - |
|
Income Before Taxes
(in mill.)
|
|
4,609 USD | 248.5000 USD | 4,779.9000 USD | 690 USD | - |
|
Net Income
(in mill.)
|
|
4,090 USD | -535.6000 USD | 4,412.6000 USD | 480 USD | - |
|
Net Income Growth Rate
|
|
-39.11% | -114.80% | 11.61% | -91.53% | - |
|
Earnings per Share
|
|
7.62 USD | -2.08 USD | 40.90 USD | 0.38 USD | - USD |
|
Total Equity
(in mill.)
|
|
5,877 USD | 16,409.6000 USD | 29,353.6000 USD | 19,246 USD | - |
|
Equity Ratio
|
|
6.40% | 72.82% | 77.74% | 32.62% | - |
|
Return on Equity
|
|
69.59% | -3.26% | 15.03% | 2.49% | - |
|
Book Value per Share
|
|
10.94 USD | 63.90 USD | 273.04 USD | 15.45 USD | - |
|
Total Assets
(in mill.)
|
|
91,839 USD | 22,533.2000 USD | 37,759.4000 USD | 58,995 USD | - |
|
Return on Assets
|
|
4.45% | -2.38% | 11.69% | 0.81% | - |
|
Operating Cash Flow
(in mill.)
|
|
11,490 USD | -492.6000 USD | 4,420.5000 USD | 10,828 USD | - |
* Latest financial year
